Abingdon Health PLC
Registered name: ABINGDON HEALTH PLC
Abingdon Health PLC made £8.4m revenue and a £3.4m loss in the year to 30 Jun 2025.
Abingdon Health PLC’s revenue grew 37% to £8.4m in the year to 30 Jun 2025, with a loss of £3.4m. The company is classified under “manufacture of other chemical products” and is based in York; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- York, Yorkshire and The Humber
- Age
- 18 yrs · since 2008
- Type
- Public Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 30 Jun 2023 | 30 Jun 2024 | 30 Jun 2025 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | £4m | £6.1m | £8.4m |
| Cost of sales | −£2m | −£2.5m | −£4.7m |
| Gross profit | £2.1m | £3.7m | £3.7m |
| Operating profit | −£3.6m | −£1.4m | −£3.5m |
| Profit before tax | −£3.6m | −£1.4m | −£3.5m |
| Profit after tax | −£3.5m | −£1.3m | −£3.4m |
| Profit (best available) | −£3.5m | −£1.3m | −£3.4m |
| Employees (average) | 82 | 85 | — |
| Ratios | |||
| Profit margin | −85.8% | −20.7% | −40.5% |
| Gross margin | 51.3% | 60% | 44.3% |
| Revenue per employee | £49.3k | £72.2k | — |
| Profit per employee | −£42.3k | −£15k | — |
| Growth (year on year) | |||
| Revenue growth | — | ▲51.7% | ▲37.4% |
| Headcount growth | — | ▲3.7% | — |
| Balance sheet — indirect signals, not revenue | |||
| Net assets | — | — | — |
| Source | Accounts · bulk data Dec 2024 | Accounts · bulk data Dec 2024 | Accounts · bulk data Dec 2025 |
How the business works
- Profit margin
- −40.5%
- Profit ÷ revenue.
- Gross margin
- 44.3%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- —
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- —
- Now —
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Subsidiaries (5)
- Forsite Diagnostics LimitedRev. £4.9m · Profit −£1.2m
- Compliance Solutions (Life Sciences) LimitedRev. £3.3m · Profit −£178k
- Abingdon Analytical LimitedRev. £518k · Profit £38k
- Ivdeology Holdings LtdRev. — · Profit −£26.2k
- Molecular Vision LimitedRev. — · Profit −£87.1k
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- A.e.v. LimitedBirkenhead · Manufacture of other chemical products n.e.c.
- Revenue
- £8.6m
- Profit
- £486k
- Staff
- 35
- Eurotek Foundry Products LimitedElland · Manufacture of other chemical products n.e.c.
- Revenue
- £8.6m
- Profit
- £90.4k
- Staff
- 18
- Rakem LimitedBury · Manufacture of other chemical products n.e.c.
- Revenue
- £8.8m
- Profit
- £37.5k
- Staff
- 28
- Celsis LimitedMargate · Manufacture of other chemical products n.e.c.
- Revenue
- £7.8m
- Profit
- £4.2m
- Staff
- 14
- Normet UK LimitedCoventry · Manufacture of other chemical products n.e.c.
- Revenue
- £9.1m
- Profit
- £164k
- Staff
- 30
- Technikraft LimitedGoole · Manufacture of other chemical products n.e.c.
- Revenue
- £9.3m
- Profit
- £557k
- Staff
- 80
Sources
Latest figures from accounts for the year to 30 Jun 2025 (profit −£3.4m), from the Companies House accounts bulk data published Dec 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.